Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity.
INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis.
Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
Demyelination and Remyelination: From Mechanism to Therapy
Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients
Episode 52 with Dr. David Tabby on migraines in MS
Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate.
A timing-of-birth effect on multiple sclerosis clinical phenotype.
BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec.
An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.
Structure of the LINGO-1-anti-LINGO-1 Li81 antibody complex provides insights into the biology of LINGO-1 and the mechanism of action of the antibody therapy.
Biogen Idec and Genentech announce restructuring of anti-CD20 collaboration agreement
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with MS.
Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases.
Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.
Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.
20th Annual Rehabilitation In Multiple Sclerosis (RIMS) Conference
Episode 48 with Dr. Bruce Cree on the EPIC, CLIMB, and SUMMIT clinical studies
Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.

Pages